Can Exercise Training Reduce the Frequency and Severity of Hot Flushes Associated With Breast Cancer Treatment?

October 10, 2023 updated by: Helen Jones, Liverpool John Moores University
In brief, this study sets out to understand if exercise training can reduce the frequency and severity of hot flushes associated with breast cancer treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In detail, the aim of this research project is to investigate whether improving temperature control mechanisms including vascular function, with exercise training is beneficial in alleviating hot flushes in breast cancer patients and their associated quality of life symptoms. Participants will be recruited at least 3-months post breast cancer treatment (surgery, radio-therapy, chemotherapy). This time point has been chosen for this study to allow patients to fully engage in the exercise intervention following treatment. All participants will be asked to attend the laboratory at Liverpool John Moores University on 4 separate occasions; 2 visits pre- and 2 visits following the exercise intervention for data collection including measures of vascular health, physical activity, sedentary behaviour, and fitness. The investigators will also gain information on food intake and incidence of hot flushes across a 7-day period pre- and post the intervention.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merseyside
      • Liverpool, Merseyside, United Kingdom, L33AF
        • Research Institute for Sport and Exercise Sciences (RISES)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Able to provide written informed consent
  • Pre-menopausal, Peri-menopausal or post-menopausal
  • >4 hot flushes per day
  • Female
  • Treated with tamoxifen or aromatase inhibitor

Exclusion Criteria:

  • Uncontrolled or severe hypertension (blood pressure > 160/100 mm Hg)
  • Any previous injury preventing exercise
  • Type 1 or 2 diabetes
  • Anti-depressants
  • Currently undergoing chemotherapy or radiotherapy
  • Current smoker
  • Cannot readily read and understand English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Intervention
Participants will complete a partially supervised 4 month exercise program consisting of 3-5 sessions/week at a moderate intensity (40-75% heart rate (HR) reserve) at Liverpool Lifestyles gyms. Participants will be given free access to the Wellness Key System© when using the Lifestyles exercise equipment which allows researchers to remotely track the exercise intensity of participants accurately.
A partially supervised 16-week moderate intensity exercise intervention consisting of 3-5 sessions per week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Thermoregulation
Time Frame: Change from pre- to post- 16 week exercise intervention
Participants will wear a tube-lined suit that allows manipulation of skin temperature by heating the water passed through the tubes. Core temperature will be increased by 1 degree (monitored using a temperature pill) with sweat rate and skin temperature recordings taken at 5minute intervals across 1 hour of heating. Thermoregulation will be compared during this hour to that of the post-exercise intervention re-test.
Change from pre- to post- 16 week exercise intervention
Change in Skin Blood Flow
Time Frame: Change from pre- to post- 16 week exercise intervention
The change in skin blood flow will be measured using laser Doppler probes at the forearm.
Change from pre- to post- 16 week exercise intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cerebral Blood Flow
Time Frame: Change from pre- to post- 16 week exercise intervention
Change in cerebral blood flow will be assessed using transcranial Doppler ultrasound to measure brain blood flow.
Change from pre- to post- 16 week exercise intervention
Change in Vascular Function
Time Frame: Change from pre- to post- 16 week exercise intervention
Vascular function will be measured via endothelial-dependent flow mediated dilation of the brachial artery and reported as a percentage change.
Change from pre- to post- 16 week exercise intervention
Change in Vascular Structure
Time Frame: Change from pre- to post- 16 week exercise intervention
Vascular structure will be measured at the carotid artery using ultrasound imaging to clearly visualise the artery. The image will be adjusted so artery wall thickness can be clearly seen with a 30 second recording taken at 3 different angles. The average of the three angles will be calculated with results reported as change in millimetres.
Change from pre- to post- 16 week exercise intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Helen Jones, Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

July 1, 2018

Study Completion (Actual)

July 1, 2018

Study Registration Dates

First Submitted

September 9, 2017

First Submitted That Met QC Criteria

September 13, 2017

First Posted (Actual)

September 18, 2017

Study Record Updates

Last Update Posted (Actual)

October 12, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Exercise Intervention

Subscribe